✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
He was treated with oral anticoagulant and mycophenolate mofetil, and is progressing favorably.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:In this article, we report the case of a 43-year-old male patient with mononeuritis multiplex associated with antiphospholipid antibodies.
📊
Key Findings & Data:The patient had no other clinical or laboratory features of other systemic or autoimmune diseases or systemic vasculitis.
💡
Conclusion & Impact:He was treated with oral anticoagulant and mycophenolate mofetil, and is progressing favorably.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
In this article, we report the case of a 43-year-old male patient with mononeuritis multiplex associated with antiphospholipid antibodies. The patient had no other clinical or laboratory features of other systemic or autoimmune diseases or systemic vasculitis. He was treated with oral anticoagulant and mycophenolate mofetil, and is progressing favorably.
🔖
Cite This Article
CORONA, L. F. V. S., N, A. D. A. B. (2020). Mononeuritis Multiplex Associated With Antiphospholipid Antibodies. art, Cilt: 35 - Sayı: 1, 146–148. https://ajindex.com/articles/206041